Apexigen, Inc.
APGN · NASDAQ
6/30/2023 | 3/31/2023 | 12/31/2022 | 9/30/2022 | |
|---|---|---|---|---|
| Market Cap | $11 | $12 | $0 | $55 |
| - Cash | $9 | $13 | $15 | $13 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | -$1 | -$15 | $43 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$6 | -$6 | -$14 | -$9 |
| % Margin | – | – | – | – |
| Net Income | -$6 | -$6 | -$7 | -$8 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.24 | -0.24 | -330.41 | -0.4 |
| % Growth | 0% | 99.9% | -82,502.5% | – |
| Operating Cash Flow | -$3 | -$7 | -$3 | $388 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$3 | -$7 | -$3 | $388 |